Display Settings:

Format

Send to:

Choose Destination
    Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7.

    [Chemoradiation for pancreatic adenocarcinoma].

    [Article in French]

    Source

    Département de radiothérapie-oncologie, EA 37-38, centre hospitalier Lyon-Sud, 69495 Pierre-Bénite cedex, France.

    Abstract

    Surgery remains the cornerstone treatment for pancreatic adenocarcinoma. However, 5% to 20% of tumors only are regarded as resectable, and, among them, only few benefit from an histological complete resection, major survival parameter. These data explain the overall poor prognosis of this disease, with a respectively 20% and 5% 1- and 5-year survival rates. These results justify an adjuvant or neoadjuvant therapeutic approach, mainly based on concurrent chemoradiation, with and without surgery. This paper reviews the different therapeutic approaches of non metastatic pancreatic adenocarcinoma.

    PMID:
    15679252
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk